Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04636892 · ClinicalTrials.gov registry record · NA
Evaluating Infrasonic Hemodynography
A NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by Scripps Health.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04636892: Recruiting NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by Scripps Health.
NCT04636892 is a NA study of Cardiovascular Diseases and Coronary Artery Disease that is actively recruiting participants, run by Scripps Health. The registered enrollment target is 25 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04636892, a NA study of Cardiovascular Diseases and Coronary Artery Disease, is actively recruiting participants, sponsored by Scripps Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system.
Conditions Studied
Interventions
- OTHER MindMics earbud
Study Locations (1)
California
- Scripps Health - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What NCT04636892 shows while recruiting
NCT04636892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which MindMics earbud is the first listed.
NCT04636892 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04636892 about?
NCT04636892 is a clinical study titled "Evaluating Infrasonic Hemodynography". This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system.
What is the current status of trial NCT04636892?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2021-01-04. Estimated completion is 2025-12-01.
What conditions does trial NCT04636892 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Artery Disease, Pulmonary Hypertension, Aortic Stenosis, Mitral Regurgitation.
What interventions are being tested in trial NCT04636892?
The interventions under investigation include: MindMics earbud (OTHER).
Who is sponsoring clinical trial NCT04636892?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04636892 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04636892's enrollment target sits among peer trials
25 271st of 300 higher than 29 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI